SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001628279-22-000483
Filing Date
2022-12-07
Accepted
2022-12-06 19:06:17
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2075415
2 backcoverlogo.jpg GRAPHIC 21702
3 business10b.jpg GRAPHIC 668648
4 business11c.jpg GRAPHIC 1449220
5 business13b.jpg GRAPHIC 249285
6 business14b.jpg GRAPHIC 289789
7 business16b.jpg GRAPHIC 360227
8 business1b.jpg GRAPHIC 194893
9 business2d.jpg GRAPHIC 529893
10 business3b.jpg GRAPHIC 671014
11 business4b.jpg GRAPHIC 386220
12 business5ca.jpg GRAPHIC 880882
13 business6b.jpg GRAPHIC 148220
14 business7da.jpg GRAPHIC 606141
15 business7dc.jpg GRAPHIC 1653435
16 business8c.jpg GRAPHIC 458539
17 imagea.jpg GRAPHIC 10122
18 mineralyslogo.jpg GRAPHIC 34244
19 mineralyslogoa.jpg GRAPHIC 30240
  Complete submission text file 0001628279-22-000483.txt   13694100
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06446 | Film No.: 221448866
SIC: 2834 Pharmaceutical Preparations